Dr. Devora Champa supports patent prosecutions in the biotechnology and life sciences areas. Her research experience includes molecular biology, cell biology and cancer biology.
As a postdoctoral scientist, Devora's research focused on identifying genetic alterations responsible for chemotherapy resistance in ovarian cancer patients by using CRISPR-Cas9 technology and cDNA library screens.
Devora received her Ph.D. from the Albert Einstein College of Medicine. As a graduate student, her research involved identifying novel signaling pathways and mechanisms responsible for tumor progression, de-differentiation and drug resistance in aggressive thyroid carcinomas. Devora has authored a number of publications based on her research.
Prior to joining the firm, she worked for four years as a technical specialist/patent agent at an IP law firm, where she focused on patent prosecution in the biotechnology and pharmaceutical fields and assisted with strategic client counseling, inter partes review (IPR) proceedings, and opinions and freedom to operate work.
She obtained her Bachelor of Science in Biology from The George Washington University, and her Ph.D. in Biomedical Sciences from the Albert Einstein College of Medicine.
Credentials
Education
- Ph.D., Biomedical Sciences, Albert Einstein College of Medicine, 2015
- B.S., Biology, The George Washington University, 2009
Admissions
- *Not admitted to the practice of law
- U.S. Patent and Trademark Office